Biomerica

Biomerica is a global biomedical technology company that develops, patents, manufactures, and markets in-vitro diagnostic (IVD) solutions and therapeutic products, with a research focus on gastrointestinal and inflammatory diseases. Its product portfolio spans diagnostic test kits (blood, urine, nasal, and fecal specimen analysis, including the hp+detect H. pylori test), the inFoods IBS platform that uses a blood sample to identify patient-specific foods that may alleviate irritable bowel syndrome symptoms, and EoGard, a diagnostic under development for eosinophilic esophagitis (EoE). Incorporated in 1971 and headquartered in Irvine, California, the company reported fiscal year-end results and announced a $2.23M private placement on August 27, 2026.